Xiong FX - Search Results

1

Development and validation of a prognostic model for 90-day survival in patients with alcohol-associated cirrhosis and acute decompensation.

Quan H, Yu H, Liu XL, Xiong FX, Hou YX, Wang XB, Yang ZY, Jiang YY. Quan H, et al. Among authors: xiong fx. Hepatol Res. 2024 Jun;54(6):588-599. doi: 10.1111/hepr.14006. Epub 2024 Jan 19. Hepatol Res. 2024. PMID: 38241146

2

Primary clear cell adenocarcinoma of the peritoneum presents as Sister Mary Joseph's nodule: a case report and literature review.

Zhang CJ, Sun GP, Liu H, Peng WR, Xiong FX, Pan YY, Da J. Zhang CJ, et al. Among authors: xiong fx. Eur J Gynaecol Oncol. 2014;35(6):745-8. Eur J Gynaecol Oncol. 2014. PMID: 25556287 Review.

3

An open-labeled, randomized, multicenter phase IIa study of gambogic acid injection for advanced malignant tumors.

Chi Y, Zhan XK, Yu H, Xie GR, Wang ZZ, Xiao W, Wang YG, Xiong FX, Hu JF, Yang L, Cui CX, Wang JW. Chi Y, et al. Among authors: xiong fx. Chin Med J (Engl). 2013;126(9):1642-6. Chin Med J (Engl). 2013. PMID: 23652044 Clinical Trial.

4

A nanomaterial-based breath test for distinguishing gastric cancer from benign gastric conditions.

Xu ZQ, Broza YY, Ionsecu R, Tisch U, Ding L, Liu H, Song Q, Pan YY, Xiong FX, Gu KS, Sun GP, Chen ZD, Leja M, Haick H. Xu ZQ, et al. Among authors: xiong fx. Br J Cancer. 2013 Mar 5;108(4):941-50. doi: 10.1038/bjc.2013.44. Br J Cancer. 2013. PMID: 23462808 Free PMC article.

5

The screening of volatile markers for hepatocellular carcinoma.

Qin T, Liu H, Song Q, Song G, Wang HZ, Pan YY, Xiong FX, Gu KS, Sun GP, Chen ZD. Qin T, et al. Among authors: xiong fx. Cancer Epidemiol Biomarkers Prev. 2010 Sep;19(9):2247-53. doi: 10.1158/1055-9965.EPI-10-0302. Cancer Epidemiol Biomarkers Prev. 2010. PMID: 20826831

6

LAPTM4B: a novel cancer-associated gene motivates multidrug resistance through efflux and activating PI3K/AKT signaling.

Li L, Wei XH, Pan YP, Li HC, Yang H, He QH, Pang Y, Shan Y, Xiong FX, Shao GZ, Zhou RL. Li L, et al. Among authors: xiong fx. Oncogene. 2010 Oct 28;29(43):5785-95. doi: 10.1038/onc.2010.303. Epub 2010 Aug 16. Oncogene. 2010. PMID: 20711237

7

Expression of LAPTM4B in gallbladder carcinoma cells: the role in invasive potential.

Zhou L, He XD, Yu JC, Zhou RL, Xiong FX, Qu Q, Rui JA. Zhou L, et al. Among authors: xiong fx. Hepatogastroenterology. 2010 Mar-Apr;57(98):207-11. Hepatogastroenterology. 2010. PMID: 20583413

8

Reduced expression of ASS is closely related to clinicopathological features and post-resectional survival of hepatocellular carcinoma.

Yang H, Lin M, Xiong FX, Yang Y, Nie X, Zhou RL. Yang H, et al. Among authors: xiong fx. Oncol Lett. 2010 Jan;1(1):31-36. doi: 10.3892/ol_00000005. Epub 2010 Jan 1. Oncol Lett. 2010. PMID: 22966251 Free PMC article.

9

LAPTM4B-35 overexpression is a risk factor for tumor recurrence and poor prognosis in hepatocellular carcinoma.

Yang H, Xiong FX, Lin M, Yang Y, Nie X, Zhou RL. Yang H, et al. Among authors: xiong fx. J Cancer Res Clin Oncol. 2010 Feb;136(2):275-81. doi: 10.1007/s00432-009-0659-4. Epub 2009 Aug 19. J Cancer Res Clin Oncol. 2010. PMID: 19690886

10

Quantitative breath analysis of volatile organic compounds of lung cancer patients.

Song G, Qin T, Liu H, Xu GB, Pan YY, Xiong FX, Gu KS, Sun GP, Chen ZD. Song G, et al. Among authors: xiong fx. Lung Cancer. 2010 Feb;67(2):227-31. doi: 10.1016/j.lungcan.2009.03.029. Epub 2009 May 5. Lung Cancer. 2010. PMID: 19409642

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10 results

Search Page

Filters